Zurueck zur Suche

Reporte zur Charge 7C75N

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

8Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
ND 1 FL 1 NJ 1 CO 1 NE 1 SD 1 OK 1 AR 1

VAERS 2694838

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 7c75n

schwer
Staat
ND
Alter
12,0
Geschlecht
F
Eingang
12.10.2023
Impfdatum
10.10.2023
Beginn
10.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Eye movement disorder Headache Immediate post-injection reaction Loss of consciousness Pallor Posture abnormal Syncope Vision blurred

Symptomtext

Mother elected to have child receive 4 vaccinations. 2 given in each arm. Two nurses injected the vaccines simultaneously. After the 2nd injection given - child immediately noted to have eyes roll back in head and slump in chair. Child regained conciousness after approx 10 seconds. Reported a headache. Child given water and fruit snacks. Said she was feeling better. HR 76, O2 98%. Child assisted back to lobby where family was. Child appeared pale, reported feeling dizzy and blurred vision. BP 80s/40s. Assisted to laying position on ground. Given more water. Cool packs place on forehead, wrists, and stomach. Encouraged to drink more water. Remained concious. BP rechecked after 10 minutes: 94/61 laying. HR 62. O2 96%. Face pink. Child reports feeling better. Approx 30 min after syncopal episode, assisted back to sitting. Recheck BP 101/64. Child able to ambulate without symptoms. Child left the office with mother.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
BP, HR, O2 checks as above.
Aktuelle Erkrankungen
none reported
Vorgeschichte
Anxiety
Andere Medikamente
citalopram Methylphenidate Dosages changed recently
Allergien
none reported
Vorherige Impfungen
-

VAERS 2680004

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 7C75N

schwer
Staat
FL
Alter
58,0
Geschlecht
M
Eingang
07.09.2023
Impfdatum
07.09.2023
Beginn
07.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Hyperhidrosis Loss of consciousness Peripheral coldness

Symptomtext

Loss of consciousness, cold extremities, profuse sweating.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
HBP
Vorgeschichte
HBP
Andere Medikamente
atenolol 25 mg tablet by oral route once daily., take 1 tablet (25 mg) by oral route once daily.
Allergien
sulfamethoxazole-trimethoprim
Vorherige Impfungen
-

VAERS 2712128

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 7C75N

mild
Staat
NJ
Alter
11,0
Geschlecht
F
Eingang
09.11.2023
Impfdatum
09.11.2023
Beginn
09.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Vomiting

Symptomtext

Vomiting, lightheadness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
Unk
Vorgeschichte
None
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 2689717

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 7C75N

mild
Staat
CO
Alter
40,0
Geschlecht
F
Eingang
02.10.2023
Impfdatum
26.09.2023
Beginn
28.09.2023
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Injection site hypoaesthesia

Symptomtext

Numbness to (R) arm from shoulder to finger tips - taken Advil

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site hypoaesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Adderall 20mg + IUD
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2715291

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 7C75N

gering
Staat
NE
Alter
-
Geschlecht
F
Eingang
18.11.2023
Impfdatum
07.11.2023
Beginn
07.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

inadvertently received BOOSTRIX on November 7, 2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 1-day-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 7C75N, expiry date 06-DEC-2025) for prophylaxis. On 07-NOV-2023, the patient received Boostrix. On 07-NOV-2023, an unknown time after receiving Boostrix, the patient experienced inappropriate age at vaccine administration (Verbatim: inadvertently received BOOSTRIX on November 7, 2023). The outcome of the inappropriate age at vaccine administration was unknown. Additional Information: GSK Receipt Date: 07-NOV-2023 The reporter was a pharmacist. The pharmacist reported that an infant inadvertently received Boostrix, which led to inappropriate age at vaccination. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2712242

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 7C75N

gering
Staat
SD
Alter
-
Geschlecht
F
Eingang
09.11.2023
Impfdatum
07.11.2023
Beginn
-
Tage bis Beginn
-
Dosis
N/A
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

No adverse events, no treatment required. Increased monitoring done. Vaccine not indicated in this age group.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
Received Erythromycin Opth. Oint. and Vitamin K 1mg.
Allergien
none known
Vorherige Impfungen
-

VAERS 2700001

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 7C75N

gering
Staat
OK
Alter
11,0
Geschlecht
F
Eingang
20.10.2023
Impfdatum
17.10.2023
Beginn
17.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

incorrect vaccine given. Parent notified. No adverse reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2691041

GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge 7C75N

gering
Staat
AR
Alter
31,0
Geschlecht
M
Eingang
05.10.2023
Impfdatum
26.09.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

received a dose of Boostrix on 26Sep2023 that was exposed to a temperature excursion; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a adult male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 7C75N, expiry date 06-DEC-2025) for prophylaxis. On 26-SEP-2023, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: received a dose of Boostrix on 26Sep2023 that was exposed to a temperature excursion).The outcome of the incorrect storage of drug was unknown. Additional Information: GSK Receipt Date: 28-SEP-2023 The reporter reported that a patient received a dose of Boostrix that was exposed to a temperature excursion, which led to incorrect storage of vaccine. No symptoms were reported. The reporter consented to follow up via email. This was 1 of 3 cases, reported by the same reporter.; Sender's Comments: US-GSK-US2023133818:same reporter different pateint,different drug US-GSK-US2023133819:samereporter different pateint,different drug US-GSK-US2023133819:same reporter different patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-